BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37708719)

  • 1. Fatty acid metabolism-related genes as a novel module biomarker for kidney renal clear cell carcinoma: Bioinformatics modeling with experimental verification.
    Jia Z; Fu Z; Kong Y; Wang C; Zhou B; Lin Y; Huang Y
    Transl Oncol; 2023 Dec; 38():101774. PubMed ID: 37708719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
    Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
    Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
    Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
    Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma.
    Zhang M; Liu YF; Gao Y; Zhao C; Chen M; Pan KH
    Transl Oncol; 2023 Aug; 34():101693. PubMed ID: 37315507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma.
    Shen Y; Cao Y; Zhou L; Wu J; Mao M
    Front Mol Biosci; 2022; 9():928006. PubMed ID: 36120545
    [No Abstract]   [Full Text] [Related]  

  • 8. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
    Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
    Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration.
    Zhang C; Huang G; Yang J; Jiang Y; Huang R; Ye Z; Huang Y; Hu H; Xi X
    Front Immunol; 2023; 14():1197011. PubMed ID: 37383233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
    Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
    Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.
    Sun Y; Xu Y; Che X; Wu G
    Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.
    Qin C; Liu S; Zhou S; Wang Q; Xia X; Hu J; Yuan X; Wang Z; Yu Y; Ma D
    Front Immunol; 2023; 14():1114572. PubMed ID: 37063922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
    Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
    Front Genet; 2022; 13():978840. PubMed ID: 36186442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation.
    Zhang X; Qin X; Yu T; Wang K; Chen Y; Xing Q
    Front Genet; 2022; 13():974726. PubMed ID: 36338996
    [No Abstract]   [Full Text] [Related]  

  • 16. A Novel KIF4A-Related Model for Predicting Immunotherapy Response and Prognosis in Kidney Renal Clear Cell Carcinoma.
    Yang GH; Ma XD; Wei XF; Liu RL; Wang C
    Comb Chem High Throughput Screen; 2024 Feb; ():. PubMed ID: 38357945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
    Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
    Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma.
    Fu S; Liu Y; Zhang Z; Mei M; Chen Q; Wang S; Yang X; Sun T; Ma M; Xie W
    J Oncol; 2022; 2022():3487859. PubMed ID: 37342680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.
    Qiu J; Wang Z; Zhao L; Zhang P; Xu Y; Xia Q
    Front Mol Biosci; 2023; 10():1201155. PubMed ID: 37529377
    [No Abstract]   [Full Text] [Related]  

  • 20. Construction and verification of a novel prognostic risk model for kidney renal clear cell carcinoma based on immunity-related genes.
    Liu Y; Wu D; Chen H; Yan L; Xiang Q; Li Q; Wang T
    Front Genet; 2023; 14():1107294. PubMed ID: 36741315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.